Search clinical trials for: DIC075V

Total 6 results

Javelin Pharmaceuticals

Completed

Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium

Healthy

United States
Javelin Pharmaceuticals

Completed

Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery

Pain, Postoperative

United States
Pfizer

Completed

An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain

Pain, Postoperative

United States
Javelin Pharmaceuticals

Completed

Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium (DFC-PK-008)

Healthy

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of DIC075V on QTc Intervals in Healthy Subjects

Ventricular Repolarization

United States
Javelin Pharmaceuticals

Completed

Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers

Healthy

United States

3

Subscribe